HD patients with IR can have reduced serum insulin concentrations after dialysis, resulting in a relative deficiency of blood insulin, as well as post-dialysis hyperglycemia due to increased hepatic gluconeogenesis capacity following HD removal of toxins [16]. Here, INS is linked to Hyperglycemia.